Falls RX, LLC (dba Ultra Care Pharmacy Baltimore)

Baltimore, MD 2020--2022 Independent Pharmacies
DEA DOJ Csa Violation Fraudulent Prescription Dispensing Red Flag Failure False Documentation
Penalty
$15,000

Outcome

U.S. District Judge Richard D. Bennett approved a consent decree on May 12, 2022, requiring Ultra Care Pharmacy Baltimore and pharmacist-owner Ketan K. Dankhara to pay $15,000 and comply with red-flag documentation requirements, after Dankhara filled dozens of fraudulent controlled substance prescriptions while also falsely documenting that he had contacted a prescriber when he had not.

Details

Ultra Care Pharmacy Baltimore — Fraudulent Prescription Dispensing / $15,000 Consent Decree (2022)

Outcome: U.S. District Judge Richard D. Bennett approved a consent decree on May 12, 2022, requiring Falls RX, LLC (dba Ultra Care Pharmacy Baltimore) and pharmacist-owner Ketan K. Dankhara to pay $15,000 in civil penalties and comply with documented red-flag assessment requirements — resolving allegations that Dankhara filled dozens of fraudulent controlled substance prescriptions between May and September 2020 while also falsely documenting that he had spoken with a prescriber when he had not.

Falls RX, LLC operates as Ultra Care Pharmacy Baltimore under pharmacist-owner Ketan K. Dankhara. Between at least May and September 2020, an individual repeatedly visited the pharmacy presenting multiple controlled substance prescriptions for numerous different patients simultaneously — many of whom had never previously been patients at the pharmacy. The presentation of bulk prescriptions for multiple patients by a single individual is a recognized diversion red flag indicating the prescriptions are being picked up by a drug dealer or diverter rather than by legitimate patients.

Despite these obvious red flags, Dankhara made no documented effort to verify whether the prescriptions were legitimate and filled several dozen fraudulent prescriptions. Additional indications of fraud were present: some fraudulent prescriptions were for the same drug, same strength, and same quantity from the same prescriber. Further, some prescriptions were written by an OB/GYN to patients who were biologically male — a clinical impossibility that should have triggered immediate scrutiny. On at least one occasion, Dankhara recorded in the pharmacy's records that he had called and spoken with the prescriber to verify the prescription, when he later admitted to investigators that no such call had taken place — a deliberate falsification of dispensing records.

The consent decree required a $15,000 civil penalty and imposed ongoing obligations requiring documentation of any red-flag indicators and the steps taken to verify prescription validity before filling prescriptions bearing such indicators.

Primary Source: Consent Decree Approved Between the United States and Baltimore-Based Pharmacy | DOJ

How Crucible Prevents This

The most serious finding in this case is not the red-flag dispensing but the falsification: Dankhara documented on a fraudulent prescription that he had spoken with the prescriber, when in fact he later admitted no such conversation occurred. Crucible's immutable DECISIONS log — append-only, session-authenticated, time-stamped — prevents retroactive falsification of dispensing records. A log entry recording prescriber contact at the time of the call is evidence; a log entry recorded hours later claiming contact occurred is detectable as out-of-sequence. The simultaneous presentation of dozens of prescriptions for multiple unrelated patients from a single individual is a red flag so obvious it would require documented justification under even the most minimal red-flag protocol.

Source: Consent Decree Approved Between the United States and Baltimore-Based Pharmacy and Pharmacist Alleged to Have Illegally Dispensed Controlled Substances | DOJ

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works